{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:40:48Z","timestamp":1784644848054,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.clbc.2012.01.006","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T14:15:08Z","timestamp":1331907308000},"page":"222-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Reversible Posterior Leukoencephalopathy Syndrome Induced by Vinorelbine"],"prefix":"10.1016","volume":"12","author":[{"given":"Yen-Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2012.01.006_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2012.01.006_bib2","article-title":"Reversible posterior leukoencephalopathy induced by carboplatin and etoposide","author":"Ryan","year":"2011","journal-title":"Med Oncol"},{"key":"10.1016\/j.clbc.2012.01.006_bib3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/archneur.1988.00520340032007","article-title":"Hypertensive encephalopathy","volume":"45","author":"Hauser","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clbc.2012.01.006_bib4","first-page":"2179","article-title":"Posterior reversible encephalopathy syndrome in infection, sepsis, and shock","volume":"27","author":"Bartynski","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clbc.2012.01.006_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1212\/WNL.40.1.167","article-title":"Neurologic involvement in toxemia of pregnancy: reversible MRI lesions","volume":"40","author":"Raroque","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.clbc.2012.01.006_bib6","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMc052954","article-title":"Reversible posterior leukoencephalopathy syndrome and bevacizumab","volume":"354","author":"Glusker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2012.01.006_bib7","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1200\/JCO.2006.08.4608","article-title":"Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006","volume":"24","author":"Govindarajan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2012.01.006_bib8","article-title":"Reversible posterior leukoencephalopathy syndrome and trastuzumab","author":"Kaneda","year":"2011","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.clbc.2012.01.006_bib9","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1200\/JCO.2007.12.8710","article-title":"Reversible posterior leukoencephalopathy syndrome induced by sunitinib","volume":"25","author":"Mart\u00edn","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2012.01.006_bib10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajem.2009.04.019","article-title":"Reversible posterior leukoencephalopathy syndrome after rituximab","volume":"28","author":"Zito","year":"2010","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.clbc.2012.01.006_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0883073807301932","article-title":"Posterior leukoencephalopathy syndrome in children and adolescents","volume":"22","author":"Alehan","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clbc.2012.01.006_bib12","first-page":"1038","article-title":"Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images","volume":"23","author":"Covarrubias","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clbc.2012.01.006_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11912-008-0013-z","article-title":"Reversible posterior leukoencephalopathy syndrome in cancer","volume":"10","author":"Vaughn","year":"2008","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clbc.2012.01.006_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archneur.1993.00540040055015","article-title":"Cranial magnetic resonance imaging in severe preeclampsia vs eclampsia","volume":"50","author":"Digre","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clbc.2012.01.006_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0733-8619(18)31167-8","article-title":"Hypertensive encephalopathy","volume":"1","author":"Dinsdale","year":"1983","journal-title":"Neurol Clin"},{"key":"10.1016\/j.clbc.2012.01.006_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2214\/ajr.162.3.8109519","article-title":"Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging","volume":"162","author":"Weingarten","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2012.01.006_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00234-009-0504-0","article-title":"Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?","volume":"51","author":"Mueller-Mang","year":"2009","journal-title":"Neuroradiology"},{"key":"10.1016\/j.clbc.2012.01.006_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00043426-200303000-00010","article-title":"Reversible posterior leukoencephalopathy syndrome in children with cancers","volume":"25","author":"Suminoe","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clbc.2012.01.006_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-199211000-00002","article-title":"The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance","volume":"54","author":"Benigni","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.clbc.2012.01.006_bib20","first-page":"1344","article-title":"MR angiography of cerebral vasospasm in preeclampsia","volume":"16","author":"Ito","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clbc.2012.01.006_bib21","first-page":"102","article-title":"Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy","volume":"24","author":"Lin","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clbc.2012.01.006_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/gyno.1998.5211","article-title":"Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature","volume":"72","author":"Al-Tweigeri","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clbc.2012.01.006_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.20147","article-title":"Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies","volume":"77","author":"Tam","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clbc.2012.01.006_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0730-725X(01)00217-X","article-title":"Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings","volume":"19","author":"Russell","year":"2001","journal-title":"Magn Reson Imaging"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820912000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820912000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:04:40Z","timestamp":1761512680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820912000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1526820912000432"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2012.01.006","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible Posterior Leukoencephalopathy Syndrome Induced by Vinorelbine","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2012.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}